01 9Rocephin
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 352
2018 Revenue in Millions : 314
Growth (%) : 12
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 281
2019 Revenue in Millions : 381
Growth (%) : -26
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 263
2020 Revenue in Millions : 267
Growth (%) : -3
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 166
2021 Revenue in Millions : 263
Growth (%) : -37
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : 5.60%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 286
2014 Revenue in Millions : 282
Growth (%) : -1%
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 295
2015 Revenue in Millions : 276
Growth (%) : 7
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 317
2016 Revenue in Millions : 316
Growth (%) : 0.3
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 308
2017 Revenue in Millions : 302
Growth (%) : 2%
LOOKING FOR A SUPPLIER?
